Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 22.04.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
22.04.XMReality AB: XMReality Interim report Group overview, January - March 202486Total order intake for Q1 2024 has increased by 54 percent compared to Q1 2023. However, net sales was down year-over-year, and the company's ARR was also down somewhat, both as a result of continued...
► Artikel lesen
22.04.CIECH Group will change its name to Qemetica in June247In June, the name of the CIECH Group companies will change. The abbreviation CIECH will be replaced by the new name: Qemetica. The planned change is a further consistent step in the Group's chemical...
► Artikel lesen
22.04.Generation Bio Co.: Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting128CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today...
► Artikel lesen
22.04.Cidara Therapeutics, Inc.: Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results223SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
► Artikel lesen
22.04.Cidara Therapeutics, Inc.: Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice351SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
► Artikel lesen
22.04.Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; Diluted Net Income Per Share - Adjusted of $1.14; and a quar91DAYTONA BEACH, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) (the "Company") announced its unaudited financial results for the first quarter of 2024. Revenues for the first...
► Artikel lesen
22.04.SmartFinancial, Inc.: SmartFinancial Announces Results for the First Quarter 2024147KNOXVILLE, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- SmartFinancial, Inc. ("SmartFinancial" or the "Company"; NYSE: SMBK), today announced net income of $9.4 million, or $0.55 per diluted common share...
► Artikel lesen
22.04.Scorpius Holdings, Inc.: Scorpius Holdings Announces Receipt of Filing Delinquency Notification455DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), received an official notice...
► Artikel lesen
22.04.First Bank Announces First Quarter 2024 Net Income of $12.5 Million458HAMILTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) (the Bank) today announced results for the first quarter of 2024. Net income for the first quarter of 2024...
► Artikel lesen
22.04.iLearningEngines Holdings, Inc.: iLearningEngines Reports Fourth Quarter and Full Year 2023 Results163Fourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, and ARR growth accelerates to 43% year-over-year BETHESDA, Md....
► Artikel lesen
22.04.Fate Therapeutics, Inc.: Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting235Key Therapeutic Mechanisms of Clinical Activity for Autoimmune Diseases, including B cell Depletion, Tissue Infiltration and Immune Reconstitution Data, from Phase 1 Study of FT819 in Relapsed / Refractory...
► Artikel lesen
22.04.BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq191HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring...
► Artikel lesen
22.04.Vertex Inc.: Vertex Provides Preliminary Financial Results for First Quarter 2024 and Announces First Quarter Earnings Call Date267KING OF PRUSSIA, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced preliminary financial results for...
► Artikel lesen
22.04.Oportun Financial Corporation: Oportun Announces Preliminary Q1 2024 Financial Information380SAN CARLOS, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Oportun Financial Corporation ("Oportun" or the "Company") (Nasdaq: OPRT), a mission-driven fintech, today announced certain preliminary unaudited...
► Artikel lesen
22.04.NBT Bancorp Inc. Announces First Quarter 2024 Results247NORWICH, N.Y., April 22, 2024 (GLOBE NEWSWIRE) -- NBT Bancorp Inc. ("NBT" or the "Company") (NASDAQ: NBTB) reported net income and diluted earnings per share for the three months ended March 31, 2024....
► Artikel lesen
22.04.Critical Metals Corp: Critical Metals Appoints Tony Sage as Chief Executive Officer160Dietrich Wanke named President of European Operations to operationalize the Wolfsberg Lithium Project, a cornerstone asset for Europe's electric vehicle industry Joint Venture with the Obeikan Investment...
► Artikel lesen
22.04.Capital Bancorp, Inc. Reports First Quarter 2024 Results521Net Income of $6.6 million, or $0.47 per share. Net Income, as adjusted(1) of $7.1 million, or $0.51 per shareROAA of 1.15% and ROAE of 10.19% for 1Q 2024Adjusted Metrics(1) excluding Merger-Related...
► Artikel lesen
22.04.Pyrophyte Acquisition Corp. Receives NYSE Notice Regarding Delayed Form 10-K Filing27HOUSTON, TEXAS, April 22, 2024 (GLOBE NEWSWIRE) -- Pyrophyte Acquisition Corp. (NYSE: PHYT) (the "Company") today announced that it received a notice from the New York Stock Exchange (the "NYSE")...
► Artikel lesen
22.04.Abeona Therapeutics Inc.: Abeona Therapeutics Provides Regulatory Update on Pz-cel157Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies related to clinical efficacy or clinical safety data in BLA, and no new...
► Artikel lesen
22.04.Clover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer306FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement technology company, today announced...
► Artikel lesen
Seite:  Weiter >>